Action Point Financial Planning’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
Action Point Financial Planning's PPH Position: Q3 2026 in Review
Action Point Financial Planning sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2026, closing a stake of 35 shares — an estimated $3.83K sold.
Action Point Financial Planning first reported a position in PPH in Q2 2026 and held it in 1 quarter. The position peaked at $3.83K in Q2 2026. 156 funds tracked by Wall St. Rank hold PPH as of Q3 2026.
- Action Point Financial Planning reported no remaining VanEck Pharmaceutical ETF position as of Q3 2026 after selling out during the quarter.
- Action Point Financial Planning sold 35 VanEck Pharmaceutical ETF shares in Q3 2026, an estimated $3.83K.
- Action Point Financial Planning first reported a position in VanEck Pharmaceutical ETF in Q2 2026 and held it in 1 quarter.
- Action Point Financial Planning's VanEck Pharmaceutical ETF position peaked at $3.83K in Q2 2026.
- 156 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.
Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.